Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Cyano-2-hydroxy-5-iodopyridine is an organic compound characterized by its unique structure, featuring a pyridine ring with a cyano group, a hydroxy group, and an iodine atom. With a chemical formula of C6H3IN2O, 3-Cyano-2-hydroxy-5-iodopyridine has a molecular weight of 262.99 g/mol and a density of 2.01 g/cm3. It is a versatile pyridine derivative that finds applications in various fields, particularly in organic synthesis and pharmaceutical development, due to its potential biological activities.

766515-33-7

Post Buying Request

766515-33-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

766515-33-7 Usage

Uses

Used in Organic Synthesis:
3-Cyano-2-hydroxy-5-iodopyridine serves as a valuable building block in organic synthesis, contributing to the creation of a wide range of chemical compounds. Its unique functional groups allow for various chemical reactions, making it a useful intermediate in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-Cyano-2-hydroxy-5-iodopyridine is utilized as a key component in the development of new drugs. Its presence in molecules can potentially enhance their biological activity, making it a promising candidate for the design of novel therapeutic agents.
Used in Antimicrobial Applications:
3-Cyano-2-hydroxy-5-iodopyridine has been studied for its antimicrobial properties, demonstrating potential as an agent against various microorganisms. Its ability to inhibit microbial growth makes it a candidate for use in antimicrobial formulations and treatments.
Used in Antitumor Applications:
3-Cyano-2-hydroxy-5-iodopyridine has also shown promise in antitumor research, indicating its potential to be developed as an anticancer agent. Its ability to target and inhibit tumor growth could lead to the development of new cancer therapies, offering hope for improved treatment options in the future.

Check Digit Verification of cas no

The CAS Registry Mumber 766515-33-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,6,5,1 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 766515-33:
(8*7)+(7*6)+(6*6)+(5*5)+(4*1)+(3*5)+(2*3)+(1*3)=187
187 % 10 = 7
So 766515-33-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H3IN2O/c7-5-1-4(2-8)6(10)9-3-5/h1,3H,(H,9,10)

766515-33-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-Iodo-2-oxo-1,2-dihydropyridine-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 5-iodo-2-oxo-1H-pyridine-3-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:766515-33-7 SDS

766515-33-7Relevant articles and documents

Original synthesis of radiolabeling precursors for batch and on resin one-step/late-stage radiofluorination of peptides

Richard, Mylène,Specklin, Simon,Roche, Mélanie,Hinnen, Fran?oise,Kuhnast, Bertrand

supporting information, p. 2507 - 2510 (2020/03/06)

Radiolabeling of peptides with fluorine-18 is hurdled by their chemical sensitivity and complicated processes. Original triflyl-pyridine intermediates afforded ammonium precursors that were radiolabeled at low temperature. From that study, a generic tag h

Derivatives of azaindoles or diazaindoles for treating pain

-

Paragraph 0179, (2014/02/15)

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING PAIN

-

Page/Page column 52, (2014/02/16)

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; for use in the treatment of pain.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING A CANCER OVEREXPRESSING TRK

-

Page/Page column 52, (2014/02/16)

The present invention relates to a compound of following formula (I) or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture, as well as pharmaceutical composition comprising such a compound, for use in the treatment of a cancer associated with the overexpression of at least one Trk protein.

Derivatives of azaindazole or diazaindazole type for treating a cancer overexpressing trk

-

Paragraph 0175-0176, (2014/02/15)

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture, as well as pharmaceutical composition comprising such a compound, for use in the treatment of a cancer associated with the overexpression of at least one Trk protein.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

-

Paragraph 0267; 0268; 0269, (2013/04/13)

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS MEDICAMENT

-

Page/Page column 54, (2012/08/08)

The present invention relates to a compound of following formula (I): or a pharmaceutically acceptable salt or solvate of same, a tautomer of same, or a stereoisomer or mixture of stereoisomers of same in any proportions, such as a mixture of enantiomers, notably a racemic mixture; as well as to the use of same as a drug, notably intended for the treatment of cancer, inflammation and neurodegenerative diseases such as Alzheimer's disease; to the use of same as a kinase inhibitor; to the pharmaceutical compositions comprising same; and to methods for the preparation of same.

Synthesis of 3,5-difunctionalized 1-methyl-1H-pyrazolo[3,4-b]pyridines involving palladium-mediated coupling reactions

Lavecchia,Berteina-Raboin,Guillaumet

, p. 6633 - 6636 (2007/10/03)

Indirect iodination of 2-chloro-nicotinonitrile gave 2-chloro-5- iodonicotinonitrile, which was cyclized with methylhydrazine to lead to 3-amino-5-iodopyrazolo[3,4-b]pyridine. Position 3 was then protected by pivaloyl group and the resulting 5-iodo-3-pivaloylaminopyrazolo[3,4-b]pyridine was engaged in palladium-promoted coupling reactions with various reagents to give 3-pivaloylamino-5-substituted compounds. Deprotection and iododediazoniation followed by cross-coupling reactions in position 3 afforded novel unsymmetrical 3,5-disubstituted pyrazolo[3,4-b]pyridine species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 766515-33-7